Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in subjects with type 2 diabetes

Updated on 9 February 2021
type 2 diabetes mellitus
type 2 diabetes
diabetes type 2


A study to evaluate an FDA approved once daily oral diabetic medication with new dosages to potentially further improve blood sugar control and increase weight loss in patients with Type 2 Diabetes.


  1. Reimbursement for time and travel
  2. You are provided study-related care and study medicine at no cost (no health insurance required)
You may help make a difference for yourself and for people like you.

Condition Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2, Diabetes
Clinical Study IdentifierTX264558
Last Modified on9 February 2021


Yes No Not Sure

Inclusion Criteria

18 years of age or older
Have a diagnosis of type 2 diabetes
Have an HbA1c value of 8.0% to 10.5%, inclusive
Body Mass Index (BMI) greater than or equal to 25 kg/m²
Additional qualification criteria exist
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note